Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.
Saved in:
| Title: | Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma. |
|---|---|
| Authors: | Walker EJ; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Goldberg D; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, California, USA., Gordon KM; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, California, USA., Pedley C; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Carnevale J; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Cinar P; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Collisson EA; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Tempero MA; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Ko AH; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Blanco AM; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, California, USA., Dhawan M; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA. |
| Source: | The oncologist [Oncologist] 2021 Nov; Vol. 26 (11), pp. e1982-e1991. Date of Electronic Publication: 2021 Sep 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
